Delivery Order EPD13009-0006
Award Date 5/11/17
Potential Completion Date 5/10/18
Potential Value $898K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed NAICS Category
Set-Aside Type
Total Small Business
Federal Contract Vehicle
- Not listed
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92121, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price delivery order contract awarded by the Environmental Protection Agency's Office of Research and Development to Acea Biosciences, Inc., a small business, for $673,520.00. The contract is for the TOXCAST program, which focuses on the microelectronic monitoring of cellular status. The work will be performed in San Diego, California. Acea Biosciences has received over 20 prior federal contract awards from various agencies, demonstrating its capabilities in supplying...
- <p>This is a task order awarded under contract EP-D-13-009 to Acea Biosciences, Inc., a small business, by the U.S. Environmental Protection Agency's Office of Research and Development. The task order, valued at $415,402.00, is for the identification of estrogen receptor agonists as part of the TOXCAST microelectronic monitoring of cellular status program. The contract is a firm fixed price delivery order.</p>
- This contract was awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute to Acea Biosciences, Inc. for the acquisition of an xCELLigence RTCA-MP equipment package. The contract is a firm fixed-price purchase order with a potential value of $134,995.95. There was no set-aside designation for this award. Acea Biosciences is a life sciences company that provides specialized equipment, software, services, and expertise related to flow...
- This federal contract award to Acea Biosciences, Inc. is for a Real-Time Label-Free Cell Analysis System. The $83,000.00 firm-fixed-price purchase order was issued by the Food and Drug Administration (FDA), a civilian agency. The contract does not have a set-aside designation. Acea Biosciences, a for-profit organization, has received over 20 prime federal contracts from agencies including the Department of Agriculture, Department of Health and Human Services, Department of Veterans Affairs,...
- This federal contract award was made by the Food and Drug Administration (FDA) to Acea Biosciences, Inc., a subsidiary of Agilent Technologies, Inc. The contract is for the delivery of a flow cytometer with post-warranty service and maintenance options, for a total ceiling value of $53,640.00. The contract was awarded on a firm fixed-price basis, with no set-aside designation. Acea Biosciences has previously received numerous prime federal contract awards from various agencies, including the...
- This federal contract award was made by the National Cancer Institute, a civilian agency within the U.S. Department of Health and Human Services, to Acea Biosciences, Inc. for the acquisition of an xCELLigence RTCA-MP equipment package. The $99,000.00 firm fixed-price purchase order does not have a set-aside designation. Acea Biosciences, a for-profit life sciences company, has received over 20 prior federal contract awards from agencies including the USDA, HHS, VA, and Navy to provide...
- This is a $55,356.00 firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Acea Biosciences, Inc., a small business vendor, to provide a Real Time Cell Analyzer (RTCA) system and related post-warranty preventive maintenance services. The award was set aside for small businesses. Acea Biosciences is a subsidiary of Agilent Technologies, Inc., a leading provider of analytical instruments, software, and services for laboratory use. This contract supports the FDA's...
- This federal contract award to Acea Biosciences, Inc. was issued by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services. The contract, valued at $96,213.60, is for the procurement of a small footprint high-dimensional flow cytometer. This equipment will be used to support research activities within the NCI. The contract has a firm fixed price pricing type and a completion date of November 16, 2016. Acea Biosciences is a life sciences company...
- This is a firm fixed-price purchase order awarded by the Food and Drug Administration to Acea Biosciences, Inc., a small business, for a preventive maintenance agreement on the company's ACEA Biosciences/xCELLigence Real-Time Cell Analysis (RTCA) Dual Purpose (DP) unit. The ceiling value of the contract is $6,600.00 with a period of performance through September 12, 2024. Acea Biosciences, Inc. is a subsidiary of the parent company Agilent Technologies, Inc., a major provider of analytical...
- This is a $17,498.00 firm fixed price purchase order contract awarded by the National Institute of Child Health and Human Development (NICHD), a civilian federal agency, to Acea Biosciences, Inc. The contract is for the delivery of specialized biological research equipment and services related to flow cytometry, cell analysis, and biosensing technology. Acea Biosciences is a life sciences company that has received numerous federal contract awards from various agencies to provide instruments,...